He Tian-Yi, Zhou Hong-Yu, Zhu Ming-Hui, Zhang Ji-Li
Health Science Center, Ningbo University, Ningbo, China.
The First Affiliated Hospital of Ningbo University, Ningbo, China.
Eur J Public Health. 2024 Aug 1;34(4):760-765. doi: 10.1093/eurpub/ckae056.
Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection exhibits multi-organ damage with diverse complications, the correlation between age, gender, medical history and clinical manifestations of novel coronavirus disease 2019 (COVID-19) patients was investigated.
1640 patients who were infected with SARS-CoV-2 and hospitalized at the First Affiliated Hospital of Ningbo University from 22 December 2022 to 1 March 2023 were categorized and analysed. Normal distribution test and variance homogeneity test were performed. Based on the test results, one-way analysis of variance, Pearson's chi-squared test and logistic regression analysis were conducted in the study.
According to the ANOVA, there was a significant difference in the age distribution (P = .001) between different clinical presentations, while gender did not (P = .06). And regression analysis showed that age, hypertension, atherosclerosis and cancer were significant hazard factors for the development of predominant clinical manifestations in patients hospitalized with novel COVID-19. Additionally, infection with SARS-CoV-2 has the potential to exacerbate the burden on specific diseased or related organs.
The elderly who are infected with SARS-CoV-2 ought to be treated with emphasis not only on antiviral therapy but also on individualized treatment that takes their medical history and comorbidities into account.
由于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染表现出多器官损害并伴有多种并发症,因此对新型冠状病毒肺炎(COVID-19)患者的年龄、性别、病史与临床表现之间的相关性进行了研究。
对2022年12月22日至2023年3月1日期间在宁波大学附属第一医院住院的1640例SARS-CoV-2感染患者进行分类和分析。进行正态分布检验和方差齐性检验。根据检验结果,在研究中进行了单因素方差分析、Pearson卡方检验和逻辑回归分析。
根据方差分析,不同临床表现之间的年龄分布存在显著差异(P = 0.001),而性别不存在显著差异(P = 0.06)。回归分析表明,年龄、高血压、动脉粥样硬化和癌症是新型COVID-19住院患者主要临床表现发生的显著危险因素。此外,SARS-CoV-2感染有可能加重特定患病或相关器官的负担。
感染SARS-CoV-2的老年人不仅应重视抗病毒治疗,还应重视考虑其病史和合并症的个体化治疗。